| Recommendations on the use of exercise testing in clinical practice P Palange, SA Ward, KH Carlsen, R Casaburi, CG Gallagher, ... European Respiratory Journal 29 (1), 185-209, 2007 | 945 | 2007 |
| Triple inhaled therapy at two glucocorticoid doses in moderate-to-very-severe COPD KF Rabe, FJ Martinez, GT Ferguson, C Wang, D Singh, JA Wedzicha, ... New England Journal of Medicine 383 (1), 35-48, 2020 | 443 | 2020 |
| Espirometría F García-Río, M Calle, F Burgos, P Casan, F Del Campo, JB Galdiz, ... Archivos de bronconeumologia 49 (9), 388-401, 2013 | 422 | 2013 |
| Use of exercise testing in the evaluation of interventional efficacy: an official ERS statement L Puente-Maestu, P Palange, R Casaburi, P Laveneziana, F Maltais, ... European Respiratory Journal 47 (2), 429-460, 2016 | 406 | 2016 |
| Consensus document on the overlap phenotype COPD–asthma in COPD JJ Soler-Cataluna, B Cosío, JL Izquierdo, JL López-Campos, JM Marín, ... Archivos de Bronconeumología (English Edition) 48 (9), 331-337, 2012 | 384 | 2012 |
| Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain J Berenguer, P Ryan, J Rodriguez-Bano, I Jarrín, J Carratala, J Pachón, ... Clinical Microbiology and Infection 26 (11), 1525-1536, 2020 | 356 | 2020 |
| Comparison of effects of supervised versus self-monitored training programmes in patients with chronic obstructive pulmonary disease L Puente-Maestu, ML Sanz, P Sanz, JM Cubillo, J Mayol, R Casaburi European Respiratory Journal 15 (3), 517-525, 2000 | 285 | 2000 |
| Validation of the ‘Test of the Adherence to Inhalers’(TAI) for asthma and COPD patients V Plaza, C Fernández-Rodríguez, C Melero, BG Cosío, LM Entrenas, ... Journal of aerosol medicine and pulmonary drug delivery 29 (2), 142-152, 2016 | 266 | 2016 |
| Effect of indacaterol on exercise endurance and lung hyperinflation in COPD DE O’Donnell, R Casaburi, W Vincken, L Puente-Maestu, J Swales, ... Respiratory medicine 105 (7), 1030-1036, 2011 | 198 | 2011 |
| Abnormal mitochondrial function in locomotor and respiratory muscles of COPD patients L Puente-Maestu, J Pérez-Parra, R Godoy, N Moreno, A Tejedor, ... European Respiratory Journal 33 (5), 1045-1052, 2009 | 186 | 2009 |
| Effects of two types of training on pulmonary and cardiac responses to moderate exercise in patients with COPD L Puente-Maestu, ML Sanz, P Sanz, JMR De Ona, ... European respiratory journal 15 (6), 1026-1032, 2000 | 154 | 2000 |
| Training improves muscle oxidative capacity and oxygenation recovery kinetics in patients with chronic obstructive pulmonary disease L Puente-Maestu, T Tena, C Trascasa, J Pérez-Parra, R Godoy, ... European journal of applied physiology 88, 580-587, 2003 | 123 | 2003 |
| Guidelines for the evaluation and treatment of muscle dysfunction in patients with chronic obstructive pulmonary disease E Barreiro, V Bustamante, P Cejudo, JB Gáldiz, J Gea, P de Lucas, ... Archivos de Bronconeumología (English Edition) 51 (8), 384-395, 2015 | 117 | 2015 |
| Dyspnea, ventilatory pattern, and changes in dynamic hyperinflation related to the intensity of constant work rate exercise in COPD L Puente-Maestu, JG de Pedro, Y Martínez-Abad, JMR de Oña, ... Chest 128 (2), 651-656, 2005 | 107 | 2005 |
| Clinical relevance of constant power exercise duration changes in COPD L Puente-Maestu, F Villar, J De Miguel, WW Stringer, P Sanz, ML Sanz, ... European Respiratory Journal 34 (2), 340-345, 2009 | 102 | 2009 |
| Health literacy and health outcomes in chronic obstructive pulmonary disease L Puente-Maestu, M Calle, JL Rodríguez-Hermosa, A Campuzano, ... Respiratory medicine 115, 78-82, 2016 | 98 | 2016 |
| Hyperinflation and its management in COPD L Puente-Maestu, WW Stringer International journal of chronic obstructive pulmonary disease 1 (4), 381-400, 2006 | 93 | 2006 |
| Development and validation of a prediction model for 30-day mortality in hospitalised patients with COVID-19: the COVID-19 SEIMC score J Berenguer, AM Borobia, P Ryan, J Rodríguez-Baño, JM Bellón, I Jarrín, ... Thorax 76 (9), 920-929, 2021 | 89 | 2021 |
| Dupilumab for COPD with type 2 inflammation indicated by eosinophil counts SP Bhatt, KF Rabe, NA Hanania, CF Vogelmeier, J Cole, M Bafadhel, ... New England Journal of Medicine 389 (3), 205-214, 2023 | 86 | 2023 |
| Nasal continuous positive airway pressure in patients with COPD in acute respiratory failure: a study of the immediate effects P De Lucas, C Tarancón, L Puente, C Rodriguez, E Tatay, JM Monturiol Chest 104 (6), 1694-1697, 1993 | 84 | 1993 |
